Characterizing fibril morphological changes by spirooxindoles for neurodegenerative disease application

Analyst. 2024 Feb 12;149(4):1229-1237. doi: 10.1039/d3an01773g.

Abstract

Fibrillation of proteins and polypeptides, which leads to the deposition of plaques in cells and tissues has been widely associated with many neuropathological diseases. Inhibition of protein misfolding and aggregation is crucial for the prevention and treatment of these conditions. The growing interest in identifying inhibitor molecules to prevent the formation of fibrils in vivo has led to the results highlighted in this study. Due to their hydrophobic structure and potential to readily cross the blood brain barrier, a library of spirooxindole compounds were synthesized with those labelled Hd-63, Hd-66 and Hd-74 proving to be the most potent against fibril formation. Our spectroscopic analysis provides detailed insight, that the introduction of these spirooxindole compounds leads to morphological changes in the mechanism of fibril formation which prevent the formation of highly ordered fibrils, instead results in the formation of disordered aggregates which are not fibrillar in nature.

MeSH terms

  • Amyloid*
  • Benzopyrans*
  • Humans
  • Neurodegenerative Diseases* / drug therapy
  • Nitriles*
  • Oxindoles*
  • Peptides / chemistry
  • Spiro Compounds*
  • Spirooxindoles

Substances

  • Amyloid
  • Spirooxindoles
  • spirooxindole
  • Peptides
  • Oxindoles
  • Benzopyrans
  • Nitriles
  • Spiro Compounds